Teva Pharmaceutical Industries (TEVA) Net Income Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -384.49% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -14.93% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -562.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.18% |
| Dec 31, 2025 | 270.91% |
| Sep 30, 2025 | 209.92% |
| Jun 30, 2025 | 132.08% |
| Mar 31, 2025 | -57.61% |
| Dec 31, 2024 | 84.69% |
| Sep 30, 2024 | -617.11% |
| Jun 30, 2024 | 3.42% |
| Mar 31, 2024 | 305.14% |
| Dec 31, 2023 | -34.63% |
| Sep 30, 2023 | 18.75% |
| Jun 30, 2023 | -226.26% |
| Mar 31, 2023 | 74.00% |
| Dec 31, 2022 | -783.44% |
| Sep 30, 2022 | -79.08% |
| Jun 30, 2022 | -232.38% |
| Mar 31, 2022 | -1,286.59% |
| Dec 31, 2021 | -195.57% |
| Sep 30, 2021 | 106.84% |
| Jun 30, 2021 | 296.23% |